http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP982571-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-58 |
| filingDate | 1998-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49180e1575d854f1a54e8d3ae30b671 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_354cad9d21e871038fa26b5188383085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d286a8f2e4507d9d1294089b5dffd252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e36600831c02bce02ffff10ace38cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3974560b90f4d5a2b745fb2d66466ac0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_103004b84a7b50984f7d2094b0d32f82 |
| publicationDate | 1999-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EC-SP982571-A |
| titleOfInvention | SERTRALINA SALTS AND SERTRALINA SUSTAINED RELEASE DOSAGE FORMS |
| abstract | Sustained-release dosage forms of esertraline that release sertraline at a rate between 1 mgA / h and 40mgA / h. Dosage forms may have an initial delay period during which sertraline is released at a rate less than 1 mgA / h. The present invention further relates to an acetate salt, an L-lactate salt and a sertraline L-aspartate salt, the pharmaceutical compositions thereof and the methods of using the salt for the treatment of various disorders and conditions. The present invention also relates to the processes for the preparation of sertraline acetate, sertraline L-lactate and sertraline L-aspartate. |
| priorityDate | 1998-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.